Last reviewed · How we verify
preoperative 0.5% ropivacaine hydrochloride preoperative
preoperative 0.5% ropivacaine hydrochloride preoperative is a Small molecule drug developed by China Medical University, China. It is currently FDA-approved. Also known as: preoperative rectus sheath block of 0.5% Ropivacaine hydrochloride.
At a glance
| Generic name | preoperative 0.5% ropivacaine hydrochloride preoperative |
|---|---|
| Also known as | preoperative rectus sheath block of 0.5% Ropivacaine hydrochloride |
| Sponsor | China Medical University, China |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Dexamethasone vs Dexmedetomidine vs Combination as Adjuvants to Popliteal Sciatic Nerve Block in Children (NA)
- Post Operative Infusion Pump Pain Study (PHASE4)
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
- Paravertebral Block vs no Block in Open Pancreaticoduodenectomy (PHASE4)
- Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
- A Study of Paravertebral Block in Thoracic Outlet Syndrome (PHASE4)
- Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- preoperative 0.5% ropivacaine hydrochloride preoperative CI brief — competitive landscape report
- preoperative 0.5% ropivacaine hydrochloride preoperative updates RSS · CI watch RSS
- China Medical University, China portfolio CI
Frequently asked questions about preoperative 0.5% ropivacaine hydrochloride preoperative
What is preoperative 0.5% ropivacaine hydrochloride preoperative?
preoperative 0.5% ropivacaine hydrochloride preoperative is a Small molecule drug developed by China Medical University, China.
Who makes preoperative 0.5% ropivacaine hydrochloride preoperative?
preoperative 0.5% ropivacaine hydrochloride preoperative is developed and marketed by China Medical University, China (see full China Medical University, China pipeline at /company/china-medical-university-china).
Is preoperative 0.5% ropivacaine hydrochloride preoperative also known as anything else?
preoperative 0.5% ropivacaine hydrochloride preoperative is also known as preoperative rectus sheath block of 0.5% Ropivacaine hydrochloride.
What development phase is preoperative 0.5% ropivacaine hydrochloride preoperative in?
preoperative 0.5% ropivacaine hydrochloride preoperative is FDA-approved (marketed).
Related
- Manufacturer: China Medical University, China — full pipeline
- Also known as: preoperative rectus sheath block of 0.5% Ropivacaine hydrochloride
- Compare: preoperative 0.5% ropivacaine hydrochloride preoperative vs similar drugs
- Pricing: preoperative 0.5% ropivacaine hydrochloride preoperative cost, discount & access